Anthony Manning
2019
In 2019, Anthony Manning earned a total compensation of $1.2M as Chief Scientific Officer at Momenta Pharmaceuticals, a 43% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $159,600 |
|---|---|
| Option Awards | $686,170 |
| Salary | $380,000 |
| Other | $14,220 |
| Total | $1,239,990 |
Manning received $686.2K in option awards, accounting for 55% of the total pay in 2019.
Manning also received $159.6K in non-equity incentive plan, $380K in salary and $14.2K in other compensation.
Rankings
In 2019, Anthony Manning's compensation ranked 8,259th out of 13,971 executives tracked by ExecPay. In other words, Manning earned more than 40.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,259 out of 13,971 | 41st |
Division Manufacturing | 3,257 out of 5,695 | 43rd |
Major group Chemicals And Allied Products | 1,232 out of 2,194 | 44th |
Industry group Drugs | 1,046 out of 1,880 | 44th |
Industry Biological Products, Except Diagnostic Substances | 237 out of 389 | 39th |
Pay ratio
| Anthony Manning's Pay | $1,239,990 |
|---|---|
| Median Employee's Pay | $210,742 |
| Pay Ratio | 6to 1 |
In 2019, the annual total compensation of Anthony Manning was $1,239,990.
The annual total compensation of the median employee at Momenta Pharmaceuticals was $210,742.
The ratio of Anthony Manning's pay to the pay of median employee was therefore 6 to one.
Source: SEC filing on April 24, 2020.
Manning's colleagues
We found four more compensation records of executives who worked with Anthony Manning at Momenta Pharmaceuticals in 2019.